Adderall vs Vyvanse
How amphetamine and lisdexamfetamine compare, two amphetamine-based stimulants for ADHD.
How they're similar
Adderall and Vyvanse are both amphetamine-class stimulants. They share a long list of features.
- Both are used to treat ADHD, and both start to work the same day they are taken.
- Both work by increasing dopamine and norepinephrine, two chemical messengers involved in attention.
- Both are Schedule II controlled substances. Both carry an FDA boxed warning about the risk of misuse and abuse.
- Both can reduce appetite, disturb sleep, and raise heart rate.
- Both are effective for ADHD when used as prescribed.
How they differ
The differences are real but narrow, and most of them trace back to one design choice. Vyvanse is a prodrug, while Adderall is taken in an already active form. The table below sums up the core points, with more detail underneath.
| Adderall (amphetamine salts) | Vyvanse (lisdexamfetamine) | |
|---|---|---|
| Drug type | Amphetamine-based stimulant | Amphetamine-based stimulant, prodrug |
| Formulations | Immediate-release and extended-release | One long-acting form |
| Onset and duration | Immediate-release is short-acting, a few hours; extended-release lasts longer | Smooth, gradual onset, long and steady from one morning dose |
| Misuse potential | Schedule II; immediate-release is more readily misused | Schedule II; prodrug design makes it somewhat harder to misuse |
| Other approved use | None beyond ADHD | Also approved for binge eating disorder in adults |
The biggest difference is the prodrug design. Vyvanse is inactive as taken, and the body gradually converts it into the active stimulant. That conversion gives a smooth, gradual onset and a long, steady effect from one morning dose. Adderall comes in an immediate-release form, which is short-acting and lasts a few hours, and an extended-release form.
That design also shapes how each one feels over a day. Vyvanse is long and smooth, with less of a peak and crash. Immediate-release Adderall is shorter, with a more noticeable rise and fall. Extended-release Adderall sits in between.
Misuse potential differs for the same reason. Because Vyvanse must be converted by the body to become active, it is somewhat harder to misuse than an immediate-release stimulant. Both are still Schedule II controlled substances, and both carry the same boxed warning.
Approved uses differ slightly. Vyvanse is also approved for binge eating disorder in adults, a condition marked by recurring episodes of eating large amounts of food with a sense of loss of control. Adderall is approved for ADHD and not for binge eating disorder.
Side effects compared
The everyday side effects of these two medications overlap closely, since both are amphetamine-class stimulants. Both can reduce appetite, disturb sleep, and raise heart rate and blood pressure. Both can cause dry mouth, headache, irritability, and a jittery feeling for some people.
The shape of the side effects can differ with the shape of the dose. Immediate-release Adderall rises and falls faster, so some people notice a sharper edge as it comes on or wears off. Vyvanse and extended-release Adderall are steadier across the day. If a side effect is severe, or it is not settling, that is a conversation to have with a prescriber rather than a reason to stop on your own.
Sleep, weight, and sexual effects
For sleep and appetite, the two are broadly similar. Both can make it harder to fall asleep, especially if taken later in the day, and both tend to reduce appetite, which can lead to some weight loss. A steadier formulation that wears off by evening can help with sleep for some people. Sexual side effects are less of a defining feature for stimulants than for antidepressants, but changes in sex drive can occur with either. Any of these effects is worth raising with a prescriber, since timing, dose, or formulation can often be adjusted.
Why a clinician might choose one over the other
Because the two are closely related, the choice often comes down to specifics.
A clinician might choose Vyvanse for a smooth, consistent, once-daily effect, or where a more misuse-resistant option is preferred. Adderall, especially the extended-release form, is also widely used for once-daily coverage. Immediate-release Adderall offers shorter or more flexible coverage, which can help when someone needs a stimulant only at certain times of day.
Beyond those points, individual response, cost, and insurance coverage often decide. The same dose can feel different from one person to the next, so some trial is normal.
The bottom line
Adderall and Vyvanse are closely related amphetamine stimulants. Vyvanse's prodrug design gives it a smoother, longer, more misuse-resistant profile, while Adderall offers both long-acting and short-acting options. The right choice is individual and is made with a prescriber. Trying one and adjusting is a normal step in treatment.
Sources
This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.
- U.S. Food and Drug Administration. Adderall (amphetamine salts) prescribing information.
- U.S. Food and Drug Administration. Vyvanse (lisdexamfetamine) prescribing information.
- MedlinePlus, U.S. National Library of Medicine.
- National Institute of Mental Health. Mental health medications.
Managing a medication needs a prescriber
Any psychiatric medication has to be started and adjusted by a clinician who can follow you over time. If you don't have a prescriber, our guides section explains the options, including in-person care and telepsychiatry, and how to choose between them.
This guide is for general education. It is not medical advice and is not a substitute for evaluation, diagnosis, or treatment by a qualified clinician. Never start, stop, or change a medication without talking to your prescriber. If you are in crisis or thinking about harming yourself, call or text 988 in the U.S. to reach the Suicide and Crisis Lifeline.